Entity type
Individual
Filer Snapshot
Andrew Cheng
CIK 0001778307. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
10
Latest filing
03 Jan 2024
Industry
n/a
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: Forms 3/4/5 owner position for AKRO. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
AKRO
09 Dec 2025 · $0
Open owner pageSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View source filing
4 filed on 03 Jan 2024 for CIK 0001778307.
- Business address
- C/O Akero Therapeutics, 601 Gateway Blvd #350, South San Francisco, CA, 94080
Filer intelligence
What SEC filings say about Andrew Cheng
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for AKRO worth $0.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
AKRO
09 Dec 2025 · President and CEO
VERA
21 May 2026
ABUS
03 Jun 2021
Latest update
What changed recently for Andrew Cheng
Latest ownership report period: 21 May 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
26 May 2026
Page type
Ownership filings
Latest period
21 May 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 26 May 2026.
SEC filing record
CIK 0001778307 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
10
First seen
13 May 2021
Latest filing
03 Jan 2024
Entity
Individual
Observed form types
3
4
CIK-linked evidence first
Latest Filings
Showing the latest 10 of 10 SEC filings for Andrew Cheng.
4
4 filing
- Filing date
- 03 Jan 2024
- Reporting date
- 02 Jan 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Dec 2023
- Reporting date
- 14 Dec 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 11 Dec 2023
- Reporting date
- 07 Dec 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 04 Oct 2023
- Reporting date
- 02 Oct 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 30 Aug 2023
- Reporting date
- 30 Aug 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 12 May 2023
- Reporting date
- 10 May 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 26 May 2022
- Reporting date
- 24 May 2022
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 May 2021
- Reporting date
- 18 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 17 May 2021
- Reporting date
- 13 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
3 filing
- Filing date
- 13 May 2021
- Reporting date
- 13 May 2021
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing